Biomimetic cell-membrane-coated metallic nanoparticles in cancer therapy: Design, functional mechanisms, and translational challenges.

Authors

Hiti Narula, Raj Kamal, Thakur Gurjeet Singh, Chander Parkash Dora, Sonia Dhiman

Published in

Nanomedicine : nanotechnology, biology, and medicine. Pages 103014. Aug 28, 2026. Epub Aug 28, 2026.

Abstract

Cancer remains a major health concern worldwide, with the need to identify better and more specific treatment measures. The concept of using metallic nanoparticles in drug delivery has attracted significant attention due to their distinct physicochemical characteristics, including surface area, size, and multifunctionality. However, their clinical use is constrained by rapid immune elimination, lack of specificity, and toxicity. To overcome these issues, metallic nanoparticles with cell-membrane-coating surfaces have become a good biomimetic platform that combines synthetic nanomaterials as well as biological activities in a single platform. These systems can be generated to have better immune evasion, long-term circulation, and better targeting because of receptor-mediated and homotypic interactions by mimicking natural cells. Additionally, stimuli-responsive controlled drug delivery increases therapeutic efficacy and decreases systemic side effects. Their effectiveness in other cancer therapies, such as photodynamic, chemodynamic, sonodynamic and immunotherapy, has been shown with greater tumour inhibition and lower toxicity in preclinical models.

PMID:
42665199
Bibliographic data and abstract were imported from PubMed on 29 Aug 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.